GLAND.BO

Gland Pharma Limited

HealthcareDrug Manufacturers - GeneralININRPeers →Country macro →

$2,255.15

Jun 12, 2026

AI Brief

Market cap

$369.14B

52w range

—

P / E

—

EPS · FY 2026

$62.28

Volume

—

Revenue · FY 2026

$64.31B

Overview Fundamentals Valuation Market Ownership & flow Narrative & AI

Explain this page

Arphra AIPlain-English read on Gland Pharma Limited’s valuation

AI Issuer Brief

Arphra AI

Loading cached brief…

Price

DB · prices_daily

1M 6M 1Y 5Y

Last

$2255.15

Change

+22.70%

Period high

$2342.00

Period low

$1597.25

Period start

$1838.002026-02-01

Through 2026-06-12

Fair value

Football field →

Weighted blend

$1,176.49

— vs spot

Recommendation

n/a

4 of 4 methods

Method spread

0bull0bear

±5% threshold

Candlestick · 1Y

Open in chart workstation →

GLAND.BO

2,255+22.70%

H 2,395L 1,575MA50 1,907MA200 —Avg vol 30K

Insider · 30d

History →

Bought

0 txns

Sold

0 txns

Net flow

+$0

Recent quarters

All financials →

Period	Revenue	Net income	EPS

Sector & industry today

Live

Sectors

Financial Services
+1.26%
Utilities
+0.83%
Communication Services
+0.46%
Energy
+0.45%
Technology
+0.34%
Consumer Defensive
-0.21%
Industrials
-0.32%
Healthcare
-0.39%
Real Estate
-0.67%
Consumer Cyclical
-0.94%
Basic Materials
-1.06%

Top industries (issuer's industry highlighted)

No industry data returned.

Analyst view

Consensus target

—

No price-target data returned for this ticker.

Recent actions

0 ↑0 ↓0 hold

No recent grade actions.

News

DB · news_items

No recent news for GLAND.BO.

Peers

No peer list available for GLAND.BO.

Total assets

$125.11B

Total debt

$2.84B

Cash & equiv

$33.59B

Operating CF

$12.31B

Free cash flow

$7.41B

Buybacks

Recent insiders

All →

Insider	Action	Shares	Value	Date
No open-market insider activity in the recent window.

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin
FY 2026	$64.31B	$12.06B	$10.27B	$62.28	+15.98%